Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Pfizer
M.D. Anderson Cancer Center
Erasca, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Jonsson Comprehensive Cancer Center
Pfizer
Solve Therapeutics